ResearchMoz

Browse All Influenza Vaccine Market Research Reports

List of reports from Influenza Vaccine

Displaying 1 to 30 (of 33 records)
China Influenza Vaccine Industry 2014 Deep Research Report
Jan 2014   |   By - QYResearch
Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2017 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises...
$2200
Research Report on China Avian Influenza Vaccine Industry, 2013 - 2017
Oct 2013   |   By - China Research and Intelligence Co., Ltd. (CRI)
In the current stage, many countries choose to cull all infected poultry to control avian influenza, instead of immunizations. The total volume of the poultry in China is over 10 billion, but more than 90% raisers only have less than 2,000 broilers. In case of epidemic diseases, it is hard to control them, which will result in huge losses. Therefore, it is quite necessary to immunize the...
$1300
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update
Sep 2013   |   By - GlobalData
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent...
$9995
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
Apr 2013   |   By - GBI Research
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict...
$3500
PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently,...
$4995
PharmaPoint: Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection....
$4995
PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently,...
$4995
PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently,...
$4995
PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently,...
$4995
PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently,...
$4995
Fluzone (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluzone (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluzone (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The...
$4995
Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold...
$3495
PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis
Nov 2012   |   By - GlobalData
PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The...
$4995
Fluzone High-Dose - (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluzone High-Dose (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluzone High-Dose (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and...
$3495
Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
Influvac (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Influvac (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Influvac (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is...
$3495
Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is...
$3495
Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is...
$3495
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market...
$3495
Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis
Nov 2012   |   By - GlobalData
Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever,...
$6995
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022
Nov 2012   |   By - GlobalData
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022 Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. Vaccination has been shown to reduce influenza morbidity and mortality and high economic burden associated with influenza illness....
$3995
Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose
Oct 2012   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose, which provides essential insights into seasonal influenza vaccines sales forecasts for the top seven countries, comprising...
$3500
China Influenza Vaccine Industry 2012 Deep Research Report
May 2012   |   By - QYResearch
Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2016 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises...
$2200
 
Displaying 1 to 30 (of 33 records)

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData

Popular Categories

 

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Upcoming Reports